Program to set national standards to reduce radiotherapy accidents
Wednesday, 25 September, 2024
A new program to develop the next generation of national standards of radiotherapy treatment hopes to reduce radiotherapy accidents over the next 30 years.
, and the are jointly developing this new set of primary standards that will be used to assess the performance of new radiotherapy techniques and cross-check each hospital鈥檚 unit devices to directly impact clinical practice at the national level.
The program aims to minimise both under-dosing and over-dosing radiotherapy treatments 鈥 these measures are expected to play a crucial role in safeguarding patient health and improving health outcomes.
Swinburne project lead Associate Professor Jeremy Brown is part of the team that will design, develop and commission these primary dosimetry standards in line with federal regulatory guidelines. 鈥淥ur cross-disciplinary approach will leverage both experimental and computational methods to deliver a set of standards that ensure the quality of healthcare-delivered cancer treatment in Australia,鈥 Brown said.
ARPANSA鈥檚鈥疍r Duncan Butler鈥痵aid the standards will improve the accuracy of radiation measurements in Australia and support new types of radiotherapy, such as protons and high dose-rate techniques.
鈥淭his work makes an important contribution to ARPANSA鈥檚 efforts to support patient safety.鈥
The project will see Swinburne, CSIRO and ARPANSA collaborating to bring together their strengths in physics, medicine and technology. The team aims to use this research project鈥檚 success to establish a leading聽Australian program and seek government- and industry-sponsored funding to develop additional advanced dosimetry tools to support the deployment of new radiotherapy modalities within Australia.
鈥淓xternal beam radiotherapy is one of the most popular approaches in the treatment of cancer in Australia. It is crucial that our team and governing bodies continue to work towards the most optimal radiotherapy treatment possible,鈥 Brown said.
This research has been funded by the CSIRO Industry PhD Program (iPhD), which is a collaboration between CSIRO, Swinburne University and ARPANSA. The CSIRO iPhD Program is part of the federal government鈥檚 University Research Commercialisation Action Plan.
The ACCC institutes Federal Court proceedings against Bupa
The ACCC has instituted Federal Court proceedings against Bupa for breaches of the Australian...
Whiteley opens $25m Human Therapeutics Plant in the Hunter
Human Therapeutics Plant, a new $25 million facility for the manufacture of alcohol-based hand...
NSW announces legislative approach to Northern Beaches 黑料吃瓜群网
Amendments have been announced that will allow NSW, if required, to terminate the Northern...